We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$1.67B
Cap. Flow
+$806M
Cap. Flow %
7.42%
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150

Sector Composition

Rank Sector Weight
1 Healthcare 38.5%
2 Technology 22.75%
3 Industrials 9.82%
4 Energy 8.34%
5 Consumer Discretionary 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZM icon
651
Zoom
ZM
$29.7B
-81,492
Closed -$5.86M
TXNM
652
TXNM Energy Inc
TXNM
$5.92B
-200,004
Closed -$8.32M
XYZ
653
Block Inc
XYZ
$47B
-3,279
Closed -$254K
KLRS
654
Kalaris Therapeutics
KLRS
$99.7M
-109,174
Closed -$1.71M
ACCD
655
DELISTED
Accolade Inc
ACCD
-240,829
Closed -$2.89M
SUM
656
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-7,443
Closed -$286K
MRO
657
DELISTED
Marathon Oil Corporation
MRO
-1,435,353
Closed -$34.7M
TWKS
658
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
-99,235
Closed -$477K
CTR
659
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
-25,991
Closed -$942K
DCPH
660
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-396,239
Closed -$6.39M
FUSN
661
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-222,462
Closed -$2.14M
CEM
662
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
-48,233
Closed -$1.93M
PGTI
663
DELISTED
PGT, Inc.
PGTI
-339,976
Closed -$13.8M
CBAY
664
DELISTED
Cymabay Therapeutics
CBAY
-532,002
Closed -$12.6M
AYX
665
DELISTED
Alteryx Inc
AYX
-597,976
Closed -$28.2M
KRTX
666
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-357,473
Closed -$113M
SPLK
667
DELISTED
Splunk Inc
SPLK
-460,000
Closed -$70.1M
TGH
668
DELISTED
Textainer Group Holdings limited
TGH
-101,220
Closed -$4.98M
SOVO
669
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-1,383,000
Closed -$30.5M
AMAM
670
DELISTED
Ambrx Biopharma Inc
AMAM
-1,255,148
Closed -$17.9M
ROVR
671
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-1,677,658
Closed -$18.3M
RYZB
672
DELISTED
RayzeBio, Inc. Common Stock
RYZB
-533,114
Closed -$33.1M
IMGN
673
DELISTED
Immunogen Inc
IMGN
-400,000
Closed -$11.9M
ESMT
674
DELISTED
EngageSmart, Inc.
ESMT
-1,215,046
Closed -$27.8M
ORTX
675
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-10,000
Closed -$165K

Similar funds

Woodline Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.

  • Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
  • Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
  • Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
  • Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
  • Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
  • Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
  • Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.

Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.